Adding pioglitazone to insulin containing regimens in type 2 diabetes: systematic review and meta-analysis.

PLoS One · 2009 · PMC2701605 · PMID 19568428

Europe PMC DOI

hedged sentence

0.0950

closest p · 1.9× alpha

0.0950

boldest claim

The sentences

did not reach statistical significancep = 0.095so close (0.05 < p ≤ 0.1)

The pioglitazone group had a lower risk but this did not reach statistical significance (HR 0.90, 95% CI 0.80 to 1.02; p = 0.095) despite the large numbers of recruits and events (at least one end-point event in 514 of the pioglitazone group and 572 of the placebo group).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.